183 related articles for article (PubMed ID: 31378369)
1. MiR-143-3p directly targets GLUT9 to reduce uric acid reabsorption and inflammatory response of renal tubular epithelial cells.
Zhou Z; Dong Y; Zhou H; Liu J; Zhao W
Biochem Biophys Res Commun; 2019 Sep; 517(3):413-420. PubMed ID: 31378369
[TBL] [Abstract][Full Text] [Related]
2. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
Torres RJ; Puig JG
Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
[TBL] [Abstract][Full Text] [Related]
3. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.
Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J
Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645
[TBL] [Abstract][Full Text] [Related]
4. [Mangiferin promotes uric acid excretion and kidney function improvement and modulates related renal transporters in hyperuricemic mice].
Hu QH; Zhang X; Wang Y; Kong LD
Yao Xue Xue Bao; 2010 Oct; 45(10):1239-46. PubMed ID: 21348301
[TBL] [Abstract][Full Text] [Related]
5. Renal Reabsorptive Transport of Uric Acid Precursor Xanthine by URAT1 and GLUT9.
Arakawa H; Amezawa N; Kawakatsu Y; Tamai I
Biol Pharm Bull; 2020; 43(11):1792-1798. PubMed ID: 33132325
[TBL] [Abstract][Full Text] [Related]
6. Effect and mechanism of dioscin from Dioscorea spongiosa on uric acid excretion in animal model of hyperuricemia.
Zhang Y; Jin L; Liu J; Wang W; Yu H; Li J; Chen Q; Wang T
J Ethnopharmacol; 2018 Mar; 214():29-36. PubMed ID: 29233733
[TBL] [Abstract][Full Text] [Related]
7. Apigenin ameliorates hyperuricemic nephropathy by inhibiting URAT1 and GLUT9 and relieving renal fibrosis via the Wnt/β-catenin pathway.
Li Y; Zhao Z; Luo J; Jiang Y; Li L; Chen Y; Zhang L; Huang Q; Cao Y; Zhou P; Wu T; Pang J
Phytomedicine; 2021 Jul; 87():153585. PubMed ID: 34044255
[TBL] [Abstract][Full Text] [Related]
8. Berberrubine attenuates potassium oxonate- and hypoxanthine-induced hyperuricemia by regulating urate transporters and JAK2/STAT3 signaling pathway.
Lin G; Yu Q; Xu L; Huang Z; Mai L; Jiang L; Su Z; Xie J; Li Y; Liu Y; Lin Z; Chen J
Eur J Pharmacol; 2021 Dec; 912():174592. PubMed ID: 34699754
[TBL] [Abstract][Full Text] [Related]
9. Nuciferine restores potassium oxonate-induced hyperuricemia and kidney inflammation in mice.
Wang MX; Liu YL; Yang Y; Zhang DM; Kong LD
Eur J Pharmacol; 2015 Jan; 747():59-70. PubMed ID: 25499818
[TBL] [Abstract][Full Text] [Related]
10. Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.
Anzai N; Ichida K; Jutabha P; Kimura T; Babu E; Jin CJ; Srivastava S; Kitamura K; Hisatome I; Endou H; Sakurai H
J Biol Chem; 2008 Oct; 283(40):26834-8. PubMed ID: 18701466
[TBL] [Abstract][Full Text] [Related]
11. Renal Handling of Uric Acid.
Andrade Sierra J; Flores Fonseca MM
Contrib Nephrol; 2018; 192():1-7. PubMed ID: 29393102
[TBL] [Abstract][Full Text] [Related]
12. Morin improves urate excretion and kidney function through regulation of renal organic ion transporters in hyperuricemic mice.
Wang CP; Wang X; Zhang X; Shi YW; Liu L; Kong LD
J Pharm Pharm Sci; 2010; 13(3):411-27. PubMed ID: 21092713
[TBL] [Abstract][Full Text] [Related]
13. SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1.
Novikov A; Fu Y; Huang W; Freeman B; Patel R; van Ginkel C; Koepsell H; Busslinger M; Onishi A; Nespoux J; Vallon V
Am J Physiol Renal Physiol; 2019 Jan; 316(1):F173-F185. PubMed ID: 30427222
[TBL] [Abstract][Full Text] [Related]
14. The Time-Feature of Uric Acid Excretion in Hyperuricemia Mice Induced by Potassium Oxonate and Adenine.
Wen S; Wang D; Yu H; Liu M; Chen Q; Bao R; Liu L; Zhang Y; Wang T
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32707836
[TBL] [Abstract][Full Text] [Related]
15. Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate.
Jutabha P; Anzai N; Kitamura K; Taniguchi A; Kaneko S; Yan K; Yamada H; Shimada H; Kimura T; Katada T; Fukutomi T; Tomita K; Urano W; Yamanaka H; Seki G; Fujita T; Moriyama Y; Yamada A; Uchida S; Wempe MF; Endou H; Sakurai H
J Biol Chem; 2010 Nov; 285(45):35123-32. PubMed ID: 20810651
[TBL] [Abstract][Full Text] [Related]
16. Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.
Hurba O; Mancikova A; Krylov V; Pavlikova M; Pavelka K; Stibůrková B
PLoS One; 2014; 9(9):e107902. PubMed ID: 25268603
[TBL] [Abstract][Full Text] [Related]
17. Fucoidan from
Zhang Y; Tan X; Lin Z; Li F; Yang C; Zheng H; Li L; Liu H; Shang J
Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33922488
[TBL] [Abstract][Full Text] [Related]
18. CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia.
Zhao ZA; Jiang Y; Chen YY; Wu T; Lan QS; Li YM; Li L; Yang Y; Lin CT; Cao Y; Zhou PZ; Guo JY; Tian YX; Pang JX
Acta Pharmacol Sin; 2022 Jan; 43(1):121-132. PubMed ID: 33767379
[TBL] [Abstract][Full Text] [Related]
19. Pallidifloside D, a saponin glycoside constituent from Smilax riparia, resist to hyperuricemia based on URAT1 and GLUT9 in hyperuricemic mice.
Wu XH; Ruan JL; Zhang J; Wang SQ; Zhang YW
J Ethnopharmacol; 2014 Nov; 157():201-5. PubMed ID: 25267580
[TBL] [Abstract][Full Text] [Related]
20. Antihyperuricemic and nephroprotective effects of resveratrol and its analogues in hyperuricemic mice.
Shi YW; Wang CP; Liu L; Liu YL; Wang X; Hong Y; Li Z; Kong LD
Mol Nutr Food Res; 2012 Sep; 56(9):1433-44. PubMed ID: 22865646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
